← Leaderboards
Sandra Cascio
Magee-Women'S Res Inst And Foundation
$1,600,259
Attributed
$2,018,236
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $929.2K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,018,236 · 2
By mechanism
R01$2,018,236 · 2
Top collaborators
- Ronald J Buckanovich2 shared
Most similar at Magee-Women'S Res Inst And Foundation
Same institution · by research overlap
- Ronald J Buckanovich$14,686,030
- Anda M Vlad$2,135,923
Others in their field
Other Rising Stars on “Transgenic Mice”
- John Alam · Eip Pharma, Inc.$10,411,018
- Amanda L. Woerman · University Of Massachusetts Amherst$4,303,175
- Baodong Sun · Duke University$3,238,660
- Rachel M Olson · University Of Missouri-Columbia$2,769,103
- Paul Tang · University Of Michigan At Ann Arbor$2,648,134
- Vishnu Hosur · Jackson Laboratory$2,568,438
Research focus
Transgenic MiceImmunotherapyTumor ImmunityCellsCd8-Positive T-LymphocytesSignal TransductionMalignant NeoplasmsTumorPhenotypeResponseCancer CellMalignant Neoplasm Of OvaryInhibitorCheckpoint TherapyKnock-DownResistanceTherapeutic TargetCancer PatientImmunityImmunocompetentProductionCell PhysiologyCd8b1 GeneMediating
Grant awards (6)
The Role of Egfl6 in Tumor Immunity$310,336
R01 · FY2025 · CA · contact PI
ALDH Inhibition as Modulator of Tumor Immunobiology$408,231
R01 · FY2024 · CA
The Role of Egfl6 in Tumor Immunity$305,930
R01 · FY2024 · CA · contact PI
The Role of Egfl6 in Tumor Immunity$215,041
R01 · FY2024 · CA · contact PI
ALDH Inhibition as Modulator of Tumor Immunobiology$427,724
R01 · FY2023 · CA
The Role of Egfl6 in Tumor Immunity$350,974
R01 · FY2023 · CA · contact PI